Dian Diagnostics Group Co Ltd
SZSE:300244

Watchlist Manager
Dian Diagnostics Group Co Ltd Logo
Dian Diagnostics Group Co Ltd
SZSE:300244
Watchlist
Price: 10.82 CNY -1.99%
Market Cap: 6.8B CNY
Have any thoughts about
Dian Diagnostics Group Co Ltd?
Write Note

Dian Diagnostics Group Co Ltd
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dian Diagnostics Group Co Ltd
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Dian Diagnostics Group Co Ltd
SZSE:300244
Current Portion of Long-Term Debt
ÂĄ951.3m
CAGR 3-Years
24%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Current Portion of Long-Term Debt
ÂĄ157.8m
CAGR 3-Years
5%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Current Portion of Long-Term Debt
ÂĄ113m
CAGR 3-Years
-7%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Current Portion of Long-Term Debt
ÂĄ65.8m
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
18%
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Current Portion of Long-Term Debt
ÂĄ1.4B
CAGR 3-Years
-7%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Jiangxi Rimag Group Co Ltd
HKEX:2522
Current Portion of Long-Term Debt
ÂĄ141m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dian Diagnostics Group Co Ltd
Glance View

Market Cap
6.8B CNY
Industry
Health Care

Nestled in the bustling city of Hangzhou, Dian Diagnostics Group Co Ltd has carved out a pivotal role in China's healthcare landscape. Established in 1996, the company's journey began with the humble yet crucial task of providing diagnostic services. Over the years, as the wave of technological innovation swept across the globe, Dian Diagnostics harnessed its potential to expand its service offerings, evolving into a comprehensive medical diagnostics powerhouse. The company operates through its expansive network of diagnostic laboratories, which leverage cutting-edge tools to deliver precise and timely results. This network serves hospitals, clinics, and other healthcare establishments, thus forming a vital link in the healthcare delivery chain. The heart of Dian Diagnostics' business model lies in its ability to integrate advanced technological solutions with healthcare needs, ensuring scalability and efficiency. The company's revenue streams primarily flow from the provision of diagnostic testing services and sales of diagnostic equipment and reagents. Owing to its commitment to innovation, Dian Diagnostics invests heavily in research and development, continuously enhancing its offerings in molecular diagnostics, pathology, and healthcare IT solutions. By catering to the ever-growing demand for reliable and rapid diagnostic services, the company sustains its growth momentum while contributing significantly to the advancement of healthcare quality in China.

Intrinsic Value
28.73 CNY
Undervaluation 62%
Intrinsic Value
Price

See Also

What is Dian Diagnostics Group Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
951.3m CNY

Based on the financial report for Sep 30, 2024, Dian Diagnostics Group Co Ltd's Current Portion of Long-Term Debt amounts to 951.3m CNY.

What is Dian Diagnostics Group Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
6%

Over the last year, the Current Portion of Long-Term Debt growth was 27%. The average annual Current Portion of Long-Term Debt growth rates for Dian Diagnostics Group Co Ltd have been 24% over the past three years , 6% over the past five years .

Back to Top